Porokeratosis Market By Therapies (Topical 5- fluorouracil, Topical Vitamin D, Imiquimod, Retinoids, Cryotherapy, Laser Therapy, Others) By End-User (Hospitals, Clinics, Diagnostic Centres, Research and academic Institutes) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2028

About this report

The Global Porokeratosis Market report explores the critical analysis of the Porokeratosis industry using key parameters. The report consists of investment strategies, the need for investments in the Porokeratosis industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the Porokeratosis industry, as well as how economic and non-economic barriers are helping the Porokeratosis market. Moreover, the report analyses the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter's five forces analysis, PESTEL analysis, value chain analysis, etc.


Key Highlights of the report

How are the major segments performing in the Porokeratosis Market?

  • In 2021, laser therapy will be the leading segment based on therapies owing to the appealing elements of laser therapy, such as the lack of an incision and the absence of hospitalization. The use of laser therapy to treat porokeratosis is gaining favor.
  • In 2021, the hospital segment will lead the market because of increased government financing, greater disposable income, and growing health concerns.

Which region dominated the Porokeratosis Market?

In 2021, North America was one of the major contributors to the global porokeratosis market. Because porokeratosis affects 10% of kidney patients, the number of cases is increasing as more than 660,000 Americans have kidney failure, and 467,000 are on dialysis. Therefore, due to the rising incidence of diffused superficial actinic porokeratosis and rising renal transplant rates, approximately 10.68% of people who received kidney transplants also had porokeratosis. In addition, the presence of major players has increased healthcare spending, and enhanced diagnostic and therapeutic options are anticipated to drive the American porokeratosis treatment market.

What is the competitive environment of the Porokeratosis Market?

Porokeratosis treatment manufacturers are implementing several expansion strategies to increase their market shares in the global porokeratosis markets. For instance, Chugai and Galderma formed an international licensing agreement for the development and marketing of Nemolizumab. Key players are investing in developing and marketing a better, more cost-effective solution for the porokeratosis market, particularly in emerging economies where minimal aesthetic spending occurs. The market is seeing an influx of innovations, and most are quickly gaining popularity. The high desire for treatments that produce quick results and involve patients for a little time is expected to restrict the market for porokeratosis. Regular product innovation presents a wide range of possibilities for reducing treatment costs.

Executive Summary

What are the effects of porokeratosis?

Porokeratosis is a group of skin conditions frequently manifest as tiny patches with a raised border. The term "porokeratosis" refers to a variety of skin conditions wherein the affected area develops pink, red, or brown pimples with a raised edge. Porokeratosis occasionally affects just one area or manifests itself in multiple locations. Porokeratosis has six basic kinds that differ in size, color, and where they manifest on the body. Porokeratosis typically no longer raises safety concerns. However, there is a chance that malignant cells could potentially develop in the afflicted locations. Porokeratosis is no longer communicable, and although it may also worsen in some areas, it is unlikely to spread by touch. Porokeratosis is a precancerous condition with the potential for the cells to transform into cancer in all of its variants radically.

Which are the key investments by the players in the Porokeratosis Industry Market?

Major businesses vigorously invest in better and more efficient therapies as funding for porokeratosis increases. As financing for porokeratosis therapy rises, there is fierce competition among the top providers, which leads to an increase in product introductions. A better and more affordable remedy is being developed and marketed by major businesses for the porokeratosis market.

Some of the major players in the market are Coherent Inc., Alma Lasers, Almirall, Allergan, Pfizer, Lumenis, Coty Inc., Cutera, Bioness Inc., Biogen, PhotoMedex Inc., Valeant Pharmaceuticals, Hologic Inc., IPG Photonics Corporation, IRIDEX Corp., Hoffman-La Roche Ltd., Biolase Inc., Angiodynamics Inc. and Beiersdorf AG, etc.

What are the Major Driving Factors for the Porokeratosis Market?

The global porokeratosis market will grow for various reasons, such as rising laser therapy demand, increased kidney transplant cases, better reimbursement laws in developed countries, rising research expenses, and rising competition among market traders. The porokeratosis market is rising because of the growing awareness of the condition and the demand for better skin. If more worldwide treatment ideas are communicated, consumers are more likely to adopt porokeratosis therapy products and procedures. Consumer awareness of the disease's malignant development is growing in industrialized nations. The market for porokeratosis will grow in response to the increased demand for personal care products. Clinical observation is sufficient to understand the malignant development of porokeratosis. The need for porokeratosis therapies has surged due to this raised awareness.

What are the Major Risks for the Porokeratosis Market?

The high cost of laser equipment, a lack of skilled or trained physicians, pharmacological side effects, and a bad healthcare system in low and middle-income nations may stymie market expansion. Porokeratosis is also a rare condition; thus, there is minimal awareness worldwide, which is a significant barrier for the market.

Which are the Key Therapies in the Porokeratosis Market?

Porokeratosis has a variety of potential treatments, including topical 5-fluorouracil, topical vitamin D, imiquimod, retinoids, cryotherapy, laser therapy, and others. In 2021, laser therapy received much attention among all the methods used to treat porokeratosis. The adoption of laser therapy for porokeratosis treatment is increasing, which further fuels the market's growth. This is due to the appealing aspects of laser therapy, such as the lack of incision and no hospitalization. Growing in popularity is the use of laser therapy to treat porokeratosis. The doctor removes the skin fragment using a laser device, allowing new skin to regenerate in its place. Patients with various types of porokeratosis were treated with laser therapy, and the results were encouraging. Consumers are increasingly choosing CO2 laser treatment since it is an easy, painless, and rapid process.

How is the Porokeratosis Market performing in regions?

In 2021, the global porokeratosis market was dominated by North America. The United States dominates the porokeratosis market because of the increased incidence of actinic porokeratosis and the rise in kidney transplant cases. 10.68% or so of kidney transplant recipients have porokeratosis. In the United States, approximately 17,000 kidney transplants were performed in 2019, according to the National Kidney Foundation, Inc. High-quality diagnostic and therapeutic options, significant health expenditures, and the presence of elite athletes are all expected to contribute to the expansion of the American medical market for porokeratosis.

Besides, the Asia Pacific market is expected to grow significantly over the forecast period with its expanding healthcare system and higher healthcare costs. Furthermore, a substantial proportion of the population in Japan is over the age of 65. Hence, the ailment is more common there. Asian countries have a higher prevalence of porokeratosis, like DSAP and Mibelli. The rise in cases is a result of a lack of awareness of the therapy among the populace; as a result, the government should take action to educate people in rural areas about the therapies, which might enhance the adoption of treatment.

What is the regulatory landscape for the Porokeratosis Market?

In developed countries, government backing and the installation of better reimbursement procedures have attracted a huge number of clients. Consumers are becoming more interested in aesthetics, particularly in wealthier countries, as disposable income and reimbursement rules increase. By raising awareness and implementing reimbursement regulations, the government can play a vital role in the porokeratosis market.

What is the Market Size of Porokeratosis regarding value?

The Porokeratosis Market is anticipated to grow at a substantial CAGR of 6.50% in the upcoming years. The Global Porokeratosis industry was estimated to be worth USD 1.6 billion in 2021 and was expected to be worth USD 2.3 billion by 2028.

What effect does COVID-19 have on the market for porokeratosis?

The recession in global economic growth has also impacted the porokeratosis market, but it has continued to grow steadily. The pandemic has, however, resulted in fewer patients visiting the clinic's doctors. The pandemic may prevent manufacturers from obtaining the chemicals in the same quantities. For the porokeratosis market, there are significant supply chain difficulties. Supply chain issues have significantly impacted the market for rare diseases like porokeratosis. However, it is anticipated that worries about health and the environment during the pandemic will have little effect on the expansion of the porokeratosis industry in the foreseeable future.

Segmentation of Global Porokeratosis Market-

Global Porokeratosis Market – By Therapies 

  • Topical 5- fluorouracil
  • Topical Vitamin D
  • Imiquimod
  • Retinoids
  • Cryotherapy
  • Laser Therapy
  • Others

Global Porokeratosis Market – By End-User

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Research and academic Institutes

Global Porokeratosis Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Frequently asked questions about the global Porokeratosis industry

The global Porokeratosis market is expected to be impacted significantly by COVID-19.

North America accounted for the highest share in the global Porokeratosis market in value.

The global porokeratosis market will grow for various reasons, such as rising laser therapy demand, an increase in kidney transplant cases, better reimbursement laws in developed countries, rising research expenses, and rising competition among market traders.

The laser therapy segment had a major share in 2021, with more than 30% of the market revenue share.

The hospital segment had a major share in 2021, with more than 30% of the market revenue share.

Porokeratosis Market Scope

Report Attribute Details
Market Value in 2021 USD 1.6 billion
Market Value in 2028 USD 2.3 billion
CAGR 6.50%
Benchmarking Year 2021
Past data 2016 – 2021
Forecast period 2022 – 2028
Choose License Type
Trusted By
Published Date:  Sep 2022
Category:  Pharmaceuticals
Report ID:   60636
Report Format:   PDF
Pages:   180
Rating:    4.8 (12)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support